ROGER WILLIAMS MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1878-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.rwmc.org
Clinical Trials
17
Active:0
Completed:6
Trial Phases
2 Phases
Phase 1:16
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Phase 1
16 (94.1%)Phase 2
1 (5.9%)Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma
Phase 1
Withdrawn
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2021-06-01
- Lead Sponsor
- Roger Williams Medical Center
- Registration Number
- NCT04270929
- Locations
- 🇺🇸
Roger Williams Medical Center, Providence, Rhode Island, United States
CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer
Phase 1
Completed
- Conditions
- Liver Metastases
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT02850536
- Locations
- 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸Roger Williams Medical Center, Providence, Rhode Island, United States
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases
Phase 1
Completed
- Conditions
- Liver Metastases
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT02416466
- Locations
- 🇺🇸
Roger Williams Medical Center, Providence, Rhode Island, United States
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Phase 1
Suspended
- Conditions
- Monitor Adverse Events
- Interventions
- Drug: Anti-PSMA Designer T Cells
- First Posted Date
- 2013-08-27
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01929239
- Locations
- 🇺🇸
Roger Williams Medical Center, Providence, Rhode Island, United States
Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds
Phase 1
Terminated
- Conditions
- Non Healing Wounds
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2016-10-04
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT01751282
- Locations
- 🇺🇸
Roger Williams Medical Center, Providence, Rhode Island, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found